Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The U.S. Food and Drug Administration (FDA) last week endorsed a strategy for a COVID-19 vaccine to be used this autumn that favours a composition different from one recently recommended by an agency advisory committee. The continuing evolution of SARS-CoV-2 makes […]
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi A panel advising the U.S. Food and Drug Administration (FDA) last week recommended that it approve a vaccine given to pregnant people to protect infants from respiratory syncytial virus (RSV), which can cause severe lung infections. https://www.science.org/content/article/news-glance-china-s-ethics-oversight-arpa-h-s-new-science-and-210-million-protein? The vote was unanimous
FDA approves new RSV vaccine; The latest health stories from around the world Read More »
The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization for Moderna’s and Pfizer-BioNTech’s updated booster vaccines, which target the BA.4/BA.5 coronavirus subvariants. www.science.org/content/article/omicron-booster-shots-are-coming-lots-questions? For the first time since the start of the pandemic, COVID-19 vaccines look set to receive an update. Boosters reformulated to protect against the Omicron variant, which has
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues Africa | All rights reserved.
